Novo Nordisk's Diet Pill Party Gets a Reality Check
Key Points
- Novo Nordisk shares dropped 2% as DBS Bank downgraded the st...
Lost your weight and your investment gains? Novo Nordisk shareholders might be feeling a bit lighter in their portfolios today as the Danish pharmaceutical giant's stock dropped 2% faster than someone on Wegovy.
From Fat Profits to Slim Pickings
The company that turned weight loss into Wall Street's favorite hobby is facing a bitter pill to swallow. DBS Bank just downgraded Novo from "buy" to "sell," apparently deciding the stock needed its own weight loss program. Growth projections have been trimmed down to a mere 16%-24% this year - practically starvation mode compared to their previous ...
While we have taken every measure to build an AI pipeline that generates credible and accuracte news, we still encourage you to conduct your own research before making investment decisions. InsAIght's content should not be considered professional financial or trading advice.